IP04-07 DEVELOPING AN ARTIFICIAL INTELLIGENCE MODEL FOR INTRAOPERATIVE IDENTIFICATION OF URINARY STONE COMPOSITION

The Journal of Urology · 2026-04-27

IP51-02 ASSESSMENT OF CHATGPT’S EFFECTIVENESS IN ENHANCING THE READABILITY OF ONLINE UROLOGIC PATIENT EDUCATION MATERIALS: CAN AI MAKE UROLOGIC HEALTH INFORMATION? MORE ACCESSIBLE?

The Journal of Urology · 2026-04-27

Editorial Comment on “Ureteral Tissue Temperature During Ureteroscopy With Ho:YAG Laser Activation in an In Vivo Porcine Model”

Urology · 2025-04-02

PD33-01 THE POUND OUT STUDY: PHENTERMINE AND TOPIRAMATE FOR URIC ACID STONE PREVENTION

The Journal of Urology · 2025-04-08

Impact of laser enucleation equipment on irrigant flow rate: an in vitro study

World Journal of Urology · 2025-05-05

Volume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF)

ASAIO Journal · 2025-04-29 · 2 citations

Acute decompensated heart failure is a common problem and is frequently associated with diuretic resistance from cardiorenal syndrome. We present the first in human use of the JuxtaFlow Renal Assist Device (RAD) to treat congestion in patients admitted to the hospital with acute decompensated heart failure. In an open-label single-arm trial, patients admitted with acute decompensated heart failure who were diuretic resistant underwent placement of the RAD catheter system and received treatment for 24 hours with RAD. The primary endpoints were safety metrics (safe use of the device) and markers of hematuria. Secondary endpoints included markers of efficacy, including 24 hour urine output and biomarkers of renal function. Seven patients underwent an implant of the RAD catheter system, with six patients successfully completing the protocol. Among patients who completed the protocol, no structural abnormalities were identified on renal ultrasound. Significant improvements in 24 hour urine output and sodium excretion were noted despite a small sample size. The volume optimization incorporating negative pressure diuresis in heart failure (VOID-HF) trial demonstrated the early feasibility of the RAD catheter system, with six of seven patients completing the protocol. Further studies are indicated to determine if this novel therapy is a safe and effective addition to current standards of care.

IP06-28 DEMOGRAPHIC RISK FACTORS FOR UNPLANNED HEALTHCARE ENCOUNTERS AFTER NEPHROLITHIASIS INTERVENTION IN THE ONEFLORIDA+ DATABASE

The Journal of Urology · 2025-04-08

Low Income and Nonwhite Race are Strongly Associated with Worse Quality of Life in Patients with Nephrolithiasis.

UNC Libraries · 2025-07-23

PURPOSE: Kidney stones are a source of significant morbidity which have been shown to negatively impact health related quality of life. We sought to understand the association between health related quality of life, socioeconomic status and race among patients with kidney stones. MATERIALS AND METHODS: Patients with stones at a total of 11 stone centers across the United States completed the WISQOL (Wisconsin Stone Quality of Life questionnaire). The patient ZIP Code™ was used to estimate household income. A mixed effects regression model was constructed for analysis with ZIP Code as the random intercept. RESULTS: A total of 2,057 stone formers completed the WISQOL. Lower income was independently associated with significantly lower health related quality of life (β = 0.372, p = 0.014), as were nonwhite race (β = -0.299, p = 0.001), unemployed work status (β = -0.291, p = 0.008), female gender (β = -0.204, p <0.001), body mass index greater than 40 kg/m² (β = -0.380, p <0.001), 5 or more medical comorbidities (β = -0.354, p = 0.001), severe recurrent stone formation (β = -0.146, p = 0.045), enrollment at an acute care visit, or a preoperative or postoperative appointment (β = -0.548, p <0.001) and recent stone symptoms (β = -0.892, p <0.001). CONCLUSIONS: Lower income, nonwhite race and unemployed work status were independently associated with lower health related quality of life among patients with kidney stones. While clinical characteristics such as body mass and stone disease severity were also associated with health related quality of life, this study shows that socioeconomic factors are similarly important. Further research to understand the specific mechanisms by which socioeconomic status and race impact health may lend insight into methods to optimize clinical treatment of stone formers and patients with other chronic diseases.

Spot Urine Oxalate Testing in a Controlled Trial of Forced Hydration and Spinach Consumption

Urology · 2025-07-29

Editorial Comment: Usage of a Mobile Health Platform for Surveillance of Kidney Stone Formers: A Prospective Study

JU Open Plus · 2025-07-01 · 1 citations

Urinary stone disease is associated with a high rate of recurrence, with 50% or more individuals experiencing another stone event within 10 years.1 Despite significant efforts, prevention remains a significant challenge. The AUA and others have put forth guidelines that cover diet, supplements, and medical therapies for stone prevention. Nonetheless, to date, stone prevention efforts have only been met with limited success. Reasons may include socioeconomic factors, lifestyle preferences, coexistent disease states, genetic factors, multifactorial etiology, and lack of strong evidence that lifestyle modifications are effective.2 Even with proposed strategies, patient adherence and compliance may be significant issues. Although these 2 terms are at times used interchangeably, they differ in specific meaning. Adherence refers to active motivation and commitment to pursuing a care plan. Compliance refers to following instructions given, while not necessarily understanding the entire rationale of the plan. The authors' objective was to develop and pilot a comprehensive mobile health kidney stone prevention care plan for patients with urolithiasis to improve quality of life, patient satisfaction, and understanding of stone health.3 The intent here is to actively engage the patient. Despite commendable efforts, only 17 (26.6%) randomized patients completed the 12-month study. Certainly, patient adherence to both a prevention plan and the study presents an additional challenge. The authors concluded that the mobile health stone prevention plan may lead to improvement in quality-of-life scores, urine volume, medication adherence, and knowledge. Importantly, using this study as a starting point, they suggest ways to improve upon their current effort that may include rewarding positive behavior, creating a more user-friendly interface, and mitigating survey fatigue with limited questions and frequency of interactions. The authors' experience and ongoing technology endeavors to further engage individuals will aid future efforts in overcoming the challenges seen in this study.